Bio-Techne Corp. (TECH)
72.31
-0.04
(-0.06%)
USD |
NASDAQ |
Aug 31, 16:00
72.34
+0.02
(+0.03%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 11.29B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 33.11% |
| Valuation | |
| PE Ratio | 62.42 |
| PE Ratio (Forward) | |
| PS Ratio | 9.340 |
| Price to Book Value | 5.354 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.08 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.1371 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 67.22% |
Profile
| Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN. |
| URL | http://www.bio-techne.com |
| Investor Relations URL | https://investors.bio-techne.com/ |
| HQ State/Province | Minnesota |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Nov. 09, 2026 (est.) |
| Last Earnings Release | Aug. 12, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 24, 2026 |
Profile
| Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN. |
| URL | http://www.bio-techne.com |
| Investor Relations URL | https://investors.bio-techne.com/ |
| HQ State/Province | Minnesota |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Nov. 09, 2026 (est.) |
| Last Earnings Release | Aug. 12, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Aug. 24, 2026 |